Broker Forecast - Societe Generale issues a broker note on GlaxoSmithKline PLC

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Societe Generale today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 2240p (from 2300p).

Broker Forecasts data provided by www.sharesmagazine.co.uk